
New study finds serious statin muscle side effects are exceptionally rare
A Lancet Digital Health study using health records from nearly 6 million UK adults shows the 10-year risk of serious statin-related muscle disorders (myopathy, myalgia, rhabdomyolysis) is about 0.04%, far lower than prior estimates. Most reported muscle symptoms are mild or due to other causes, and risk is influenced by factors like kidney disease, other medications, and vitamin D deficiency. Clinicians can personalize risk with new tools; statins remain highly beneficial for lowering LDL and reducing heart attack or stroke risk, and patients should discuss risks with their doctor rather than fear rare side effects.











